Browse by all authors Browse By Author ID - Nicol, Andrew J.

Browse Results (45 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Nieda, M., Nicol, A. J., Koezuka, Y., Kikuchi, A., Takahashi, T., Nakamura, H., Furukawa, H., Yabe, T., Ishikawa, Y., Tadokoro, K. and Juji, T. (1999) Activation of human Valpha24NKT cells by alpha-glycoslceramide in a CD1d-restricted and Valpha24TCR-mediated manner. Human Immunology, 60 1: 10-19. doi:10.1016/S0198-8859(98)00100-1 45   84 Cited 88 times in Scopus88 0
Nieda, M, Nicol, A, Koezuka, Y, Kikuchi, A, Takahashi, T, Nakamura, H, Furukawa, H, Yabe, T, Ishikawa, Y, Tadokoro, K and Juji, T (1999) Activation of human V alpha 24NKT cells by alpha-glycosylceramide in a CD1d-restricted and V alpha 24TCR-mediated manner. HUMAN IMMUNOLOGY, 60 1: 10-19. doi:10.1016/S0198-8859(98)00100-1 39   84 Cited 88 times in Scopus88 0
Nicol, A., Nieda, M., Donaldson, C., DenningKendall, P., Bradley, B. and Hows, J. (1995) Analysis of cord blood CD34+ cells purified after cryopreservation. Experimental Hematology, 23 14: 1589-1594. 39   32 Cited 35 times in Scopus35
Takahashi, T., Nieda, M., Koezuka, Y., Nicol, A., Porcelli, S.A., Ishikawa, Y., Tadokoro, K., Hirai, H. and Juji, T. (2000) Analysis of human V alpha 24(+) CD4(+) NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. Journal of Immunology, 164 9: 4458-4464. 38   121 Cited 122 times in Scopus122
Lin, H, Nieda, M, Rozenkov, V and Nicol, AJ (2006) Analysis of the effect of different NKT cell subpopulations on the activation of CD4 and CD8 T cells, NK cells, and B cells. Experimental Hematology, 34 3: 289-295. doi:10.1016/j.exphem.2005.12.008 81   15 Cited 17 times in Scopus17 0
Mattarollo, Stephen R., Kenna, Tony, Nieda, Mie and Nicol, Andrew J. (2007) Chemotherapy and zoledronate sensitize solid tumour cells to V γ9Vδ2T cell cytotoxicity. Cancer Immunology Immunotherapy, 56 8: 1285-1297. doi:10.1007/s00262-007-0279-2 592   60 Cited 68 times in Scopus68 0
Mattarollo, Stephen R., Kenna, Tony, Niedal, Mie and Nicol, Andrew J. (2006) Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V alpha 24(+) NKT cell-mediated cytotoxicity. International Journal of Cancer, 119 7: 1630-1637. doi:10.1002/ijc.22019 89   21 Cited 24 times in Scopus24 0
Körner, R.J, Nicol, A., Reeves, D.S., MacGowan, A.P and Hows, J. (1994) Ciprofloxacin resistant Serratia marcescens endocarditis as a complication of non-Hodgkin's lymphoma. Journal of Infection, 29 1: 73-76. doi:10.1016/S0163-4453(94)95141-1 34   13 Cited 18 times in Scopus18 0
Abe, Yu, Muto, Masato, Nieda, Mie, Nakagawa, Yasunori, Nicol, Andrew, Kaneko, Touru, Goto, Shigenori, Yokokawa, Kiyoshi and Suzuki, Kenshi (2009) Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma. Experimental Hematology, 37 8: 956-968. doi:10.1016/j.exphem.2009.04.008 425   42 Cited 53 times in Scopus53 0
Denning-Kendall, P. A., Horsley, H., Nicol, A., Nieda, M., Bradley, B. and Hows, J. M. (1998) Clinical application of in vitro expansion of cord blood. Bone Marrow Transplantation, 22 Suppl 1: S63-S65. 32   4 Cited 4 times in Scopus4
Nicol, A. J., Tokuyama, H., Mattarollo, S. R., Hagi, T., Suzuki, K., Yokokawa, K. and Nieda, M. (2011) Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours. British Journal of Cancer, 105 6: 778-786. doi:10.1038/bjc.2011.293 57   30 Cited 32 times in Scopus32 0
Lin, H., Nieda, M., Hutton, J. F., Rozenkov, V. and Nicol, A. J. (2006) Comparative gene expression analysis of NKT cell subpopulations. Journal of Leukocyte Biology, 80 1: 164-173. doi:10.1189/jlb.0705421 49   14 Cited 16 times in Scopus16 0
Nicol, Andrew J., Tazbirkova, Andrea and Nieda, Mie (2011) Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of alpha-GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells. Clinical Cancer Research, 17 15: 5140-5151. doi:10.1158/1078-0432.CCR-10-3105 31   10 Cited 10 times in Scopus10 0
Takahara, M., Miyai, M., Tomiyama, M., Mutou, M., Nicol, A.J. and Nieda, M. (2008) Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vy9y T cell activation. Journal of Leukocyte Biology, 83 3: 742-754. doi:10.1189/jlb.0307185 330   19 Cited 20 times in Scopus20 0
Hows, J., Nicol, A., DenningKendall, P., Donaldson, C., Nieda, M. and Bradley, B. (1996) Cord blood as an alternative source of haemopoietic stem cells. Annals of Oncology, 7 Suppl 2: 47-51. doi:10.1093/annonc/7.suppl_2.47 23   5 Cited 7 times in Scopus7 0
Nicol, Andrew J., Hows, Jill M. and Bradley, Benjamin A. (1994) Cord blood transplantation: a practical option?. British Journal of Haematology, 87 1: 1-5. doi:10.1111/j.1365-2141.1994.tb04862.x 18   13 Cited 7 times in Scopus7 0
Nicol, Andrew, Nieda, Mie, Donaldson, Craig, Denning-Kendall, Patricia, Truman, Carol, Bradley, Ben and Hows, Jill (1996) Cryopreserved human bone marrow stroma is fully functional in vitro. British Journal of Haematology, 94 2: 258-265. doi:10.1046/j.1365-2141.1996.d01-1812.x 42   16 Cited 15 times in Scopus15 0
Nicol, A. J., Kikuchi, A., Nieda, M., Hutchins, C., Horley, D., Henry, J. and Durrant, S. T. (1999). Cytotoxic T-Lymphocyte therapy for a patient with chronic myeloid leukaemia. In: Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (65). 21 - 29 Oct, 1999. 29  
Giles, N., Henry, J., Horley, D. and Nicol, A. J. (1999). Dendritic cell (DC) therapy for patients with solid tumors. In: Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (76). 21 - 27 Oct, 1999. 69  
Nicol, A. J., Nieda, M., Koezuka, Y., Porcelli, S., Suzuki, K., Tadokoro, K., Durrant, S. T. and Juji, T. (2000) Dendritic cells are targets for human invariant Valpha24+ natural killer T-cell cytotoxic: An important immune regulatory function. Experimental Hematology, 28 3: 276-282. doi:10.1016/S0301-472X(99)00149-6 44   26 Cited 28 times in Scopus28 0
Nieda, M, Kikuchi, A, Nicol, A, Koezuka, Y, Ando, Y, Ishihara, S, Lapteva, N, Yabe, T, Tokunaga, K, Tadokoro, K and Juji, T (2001) Dendritic cells rapidly undergo apoptosis in vitro following culture with activated CD4(+) V alpha 24 natural killer T cells expressing CD40L. Immunology, 102 2: 137-145. doi:10.1046/j.1365-2567.2001.01175.x 57   13 Cited 12 times in Scopus12 0
Nieda, Mie, Nicol, Andrew, Kikuchi, Akiko, Kashiwase, Koichi, Taylor, Kerry, Suzuki, Kenji, Tadokoro, Kenji and Juji, Takeo (1998) Dendritic cells stimulate the expansion of bcr-abl specific CD8(+) T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia. Blood, 91 3: 977-983. 44   109 Cited 116 times in Scopus116
Lin, H, Nieda, M and Nicol, AJ (2004) Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines. European Journal of Immunology, 34 10: 2664-2671. doi:10.1002/eji.200324834 74   30 Cited 30 times in Scopus30 0
Crough, T, Nieda, M, Morton, J, Bashford, J, Durrant, S and Nicol, AJ (2002) Donor-derived b2a2-specific T cells for immunotherapy of patients with chronic myeloid leukemia. Journal of Immunotherapy, 25 6: 469-475. doi:10.1097/00002371-200211000-00003 79   4 Cited 6 times in Scopus6 0
Nieda, Mie, Terunuma, Hiroshi, Eiraku, Yuuta, Deng, Xuewen and Nicol, Andrew J. (2014) Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56high+ Interferon-α-induced dendritic cells. Experimental Dermatology, 24 1: 35-41. doi:10.1111/exd.12581 12   0 Cited 0 times in Scopus0 1
Tazbirkova, A., Okai, M., Horley, D. C., Crough, T. M., Maksoud, A., Nieda, M. and Nicol, A. J. (2003) Effects of leukapheresis protocol, cell processing and cryopreservation on the generation of monocyte-derived DC for immune therapy. Cytotherapy, 5 1: 31-39. doi:10.1080/14653240310000056 191   3 Cited 3 times in Scopus3 0
Nieda, Mie, Nicol, Andrew, Denning-Kendall, Patricia, Sweetenham, John, Bradley, Ben and Hows, Jill (1997) Endothelial cell precursors are normal components of human umbilical cord blood. British Journal of Haematology, 98 3: 775-777. doi:10.1046/j.1365-2141.1997.2583074.x 36   100 Cited 115 times in Scopus115 0
Lapteva, N, Nieda, M, Ando, Y, Nicol, A, Ide, K, Yamaura, A, Hatta-Ohashi, Y, Egawa, K, Juji, T and Tokunaga, K (2001) Gene expression analysis in human monocytes, monocyte-derived dendritic cells, and alpha-galactosylceramide-pulsed monocyte-derived dendritic cells. Biochemical And Biophysical Research Communications, 289 2: 531-538. doi:10.1006/bbrc.2001.6003 56   8 Cited 8 times in Scopus8 1
Crough, T, Nieda, M and Nicol, AJ (2004) Granulocyte colony-stimulating factor modulates alpha-galactosylceramide-responsive human V alpha 24(+) V beta 11(+) NKT cells. Journal of Immunology, 173 8: 4960-4966. 82   14 Cited 15 times in Scopus15
Nicol, A. J., Nieda, M., Koezuka, Y., Porcelli, S., Tadokoro, K., Durrant, S. T. and Juji, T. (2000) Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic antitumour activity through mechanisms distinct from T cells and natural killer cells.. Immunology, 99 2: 229-234. doi:10.1046/j.1365-2567.2000.00952.x 34   84 Cited 87 times in Scopus87 0
Okai, M, Nieda, M, Tazbirkova, A, Horley, D, Kikuchi, A, Durrant, S, Takahashi, T, Boyd, A, Abraham, R, Yagita, H, Juji, T and Nicol, A (2002) Human peripheral blood V alpha 24(+) V beta 11(+) NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells. Vox Sanguinis, 83 3: 250-253. doi:10.1046/j.1423-0410.2002.00217.x 67   35 Cited 35 times in Scopus35 0
Nicol, A. J., Kikuchi, A., Nieda, M., Schmidt, C., Giles, N., Horley, D., Henry, J. and Durrant, S. T. (1999). Human Va24+ NKT cells have anti-tumour activity against human melanoma. In: Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (65). 21 - 27 Oct, 1999. 49  
Kikuchi, A., Nieda, M., Schmidt, C., Koezuka, Y., Ishihara, S., Ishikawa, Y., Tadokoro, K., Durrant, S., Boyd, A., Juji, T. and Nicol, A. (2001) In vitro anti-tumour activity of α-galactosylceramide-stimulated human invariant Vα24+NKT cells against melanoma. British Journal of Cancer, 85 5: 741-746. doi:10.1054/bjoc.2001.1973 95   36 Cited 40 times in Scopus40 0
Denning-Kendall, P.A., Nicol, A., Horsley, H., Donaldson, C., Bradley, B. and Hows, J.M. (1998) Is in vitro expansion of human cord blood cells clinically relevant?. Bone Marrow Transplantation, 21 3: 225-232. doi:10.1038/sj.bmt.1701078 16   25 Cited 22 times in Scopus22 0
Crough, T, Purdie, DM, Okai, M, Maksoud, A, Nieda, M and Nicol, AJ (2004) Modulation of human V alpha 24(+)V beta 11(+) NKT cells by age, malignancy and conventional anticancer therapies. British Journal of Cancer, 91 11: 1880-1886. doi:10.1038/sj.bjc.6602218 67   33 Cited 31 times in Scopus31 0
Donaldson, C., Armitage, W.J., Denning-Kendall, P.A., Nicol, A.J., Bradley, B.A. and Hows, J.M. (1996) Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplantation, 18 4: 725-731. 27   64 Cited 60 times in Scopus60
Denning-Kendall, P., Donaldson, C., Nicol, A., Bradley, B. and Hows, J. (1996) Optimal processing of human umbilical cord blood for clinical banking. Experimental Hematology, 24 12: 1394-1401. 47   43 Cited 47 times in Scopus47
Henderson, RD, Rajah, T, Nicol, AJ and Read, SJ (2003) Posterior leukoencephalopathy following, intrathecal chemotherapy with MRA-documented vasospasm. Neurology, 60 2: 326-328. 81   58 Cited 73 times in Scopus73
Lickliter, J. D., Cox, J., McCarron, J., Martinez, N. R., Schmidt, C. W., Lin, H., Nieda, M. and Nicol, A. J. (2007) Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction. British Journal of Cancer, 96 4: 600-608. doi:10.1038/sj.bjc.6603599 59   23 Cited 26 times in Scopus26 0
Deng, Xuewen, Terunuma, Hiroshi, Nieda, Mie, Xiao, Weihua and Nicol, Andrew (2012) Synergistic cytotoxicity of ex vivo expanded natural killer cells in combination with monoclonal antibody drugs against cancer cells. International Immunopharmacology, 14 4: 593-605. doi:10.1016/j.intimp.2012.09.014 39   2 Cited 3 times in Scopus3 0
Kashiwase, K, Kikuchi, A, Ando, Y, Nicol, A, Porcelli, SA, Tokunaga, K, Omine, M, Satake, M, Juji, T, Nieda, M and Koezuka, Y (2003) The CD1d natural killer T-cell antigen presentation pathway is highly conserved between humans and rhesus macaques. Immunogenetics, 54 11: 776-781. doi:10.1007/s00251-002-0527-8 40   17 Cited 17 times in Scopus17 0
Nieda, M, Okai, M, Tazbirkova, A, Lin, H, Yamaura, A, Ide, K, Abraham, R, Juji, T, Macfarlane, DJ and Nicol, AJ (2004) Therapeutic activation of V alpha 24(+)V beta 11(+) NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood, 103 2: 383-389. doi:10.1182/blood-2003-04-1155 590   229 Cited 239 times in Scopus239 0
Kenealy, MK, Seymour, JF, Linda, C, Milner, A, Benson, W, Nicol, A, Campbell, P, Prosser, I, Underhill, C, Cunningham, I, Mills, AK, Szer, J, Presgrave, P and Filshie, R (2009). The Tolerability of Combination Therapy with Thalidomide and 5-Azacitidine in Patients with Advanced Myelodysplastic Syndromes (MDS).. In: BLOOD. 51st Annual Meeting of the American-Society-of-Hematology, New Orleans LA, (695-695). DEC 05-08, 2009. 34   0
Nieda, M, Nicol, A, Koezuka, Y, Kikuchi, A, Lapteva, N, Tanaka, Y, Tokunaga, K, Suzuki, K, Kayagaki, N, Yagita, H, Hirai, H and Juji, T (2001) TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukema cells. Blood, 97 7: 2067-2074. doi:10.1182/blood.V97.7.2067 57   103 Cited 103 times in Scopus103 0
Tokuyama, Hirotake, Hagi, Tomomi, Mattarollo, Stephen R, Morley, Jacqueline, Wang, Qiao, Fai-So, Hang, Moriyasu, Fuminori, Nieda, Mie and Nicol, Andrew J. (2008) Vy9V 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs - Rituximab and trastuzumab. International Journal of Cancer, 122 11: 2526-2534. doi:10.1002/ijc.23365 65   48 Cited 56 times in Scopus56 0